NEWARK, DEL, Oct. 04, 2023 (GLOBE NEWSWIRE) -- The global minimally invasive neurosurgery devices market size is likely to jump from US$ 3,227.9 million in 2023 to US$ 5,950.1 million by 2033. This projected expansion is anticipated to result from a modest 6.3% CAGR in the demand for minimally invasive neurosurgery devices over the upcoming decade.
| Minimally Invasive Neurosurgery Devices Market Size (2023) | US$ 3,227.9 million | |
| Minimally Invasive Neurosurgery Devices Market Projected Size (2033) | US$ 5,950.1 million | |
| Forecasted Value CAGR (2023 to 2033) | 6.3 | % |
Request for a sample of this research report: https://www.futuremarketinsights.com/reports/sample/rep-gb-956
An upward trend in neurological illnesses is one of the driving drivers for this industry, and awareness of this market is expanding in emerging nations. The evolution of technology in neurosurgery, such as surgeries previously deemed unattainable, has become achievable with minimal neurosurgical equipment with a high efficacy and recuperation rate. The enhanced recuperative capabilities and swifter healing process following surgery render it a more efficient therapeutic approach. Consequently, numerous patients opt for minimally invasive neurosurgery instead of conventional surgical treatments.
The growing prevalence of coronary artery disease fuels the expansion of the minimal neurosurgery device market. According to a National Institute of Health report, around 276 million people have problems with the vascular that necessitate fluoroscopy. In addition, recent developments in endoscope design have resulted in integrated, efficient endoscopes with increased resolution and illumination. This is likely to boost the growth of the minimally invasive neurosurgery device market.
Minimally invasive procedures often lead to lower healthcare costs in the long run. Shorter hospital stays, fewer complications, and quicker recovery times translate into cost savings for patients and healthcare providers. The shift toward personalized medicine is influencing neurosurgery as well. Minimally invasive techniques are now being applied to multiple neurosurgical procedures, including functional neurosurgery for conditions like epilepsy and Parkinson's disease. This trend is broadening the scope of the market.
Numerous innovations have taken place in the minimally invasive neurosurgical device market landscape. These include advancements in neurosurgical devices, such as an endoscope, and the invention of surgical tools that require minimal opening and disclosure of the surgical zone. The utilization of these technologies has created new prospects in the neurosurgical sector, and difficult procedures can currently be carried out with their assistance.
“Some of the best hospitals for brain surgeries are found in the United Kingdom, Germany, and the United States. But then again, getting treatment there can be quite pricey. In countries like India and China, though, the cost for procedures like neurological surgeries is roughly half of what one would pay in these developed nations. This shift in patient behavior will likely drive the demand for minimally invasive neurosurgery devices in developing countries.” Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
Key Takeaways from the Minimally Invasive Neurosurgery Devices Market:
- In 2022, the United States firmly established itself as a leader in the minimally invasive neurosurgery devices industry, commanding a 33.7% global market share.
- The minimally invasive neurosurgery devices industry in the United Kingdom is positioned for significant expansion, with an estimated CAGR of 4.4% anticipated through 2033.
- Japan’s minimally invasive neurosurgery devices industry secured a market share of 4.1% in 2022.
- India's notable progress in the minimally invasive neurosurgery devices market is reflected in its anticipated CAGR of 6.2% over the forecasted period.
- In 2022, Germany possessed a significant 8.7% portion of the global minimally invasive neurosurgery devices industry.
- China is poised for swift ascent in the minimally invasive neurosurgery devices industry, with an estimated CAGR of 7.6% anticipated over the forecasted period.
Ready to Learn About Our Approach? Explore Our Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-956
Key Players and Strategies for Success in the Minimally Invasive Neurosurgery Devices Market
Here are the key players' top strategies for success in the minimally invasive neurosurgery devices industry:
- Investing heavily in research and development to develop cutting-edge minimally invasive neurosurgery technologies.
- Forming strategic alliances with hospitals, research institutions, and other industry players to enhance product development.
- Establishing a strong presence in regions with increasing demand for minimally invasive neurosurgery devices.
- Offering a range of customizable products to cater to neurosurgeons and patients' specific needs and preferences.
- Identifying unique features and benefits of their products to distinguish themselves from competitors.
The Major Key Players Are:
- Karl Storz GmbH & Co. KG
- Olympus Corporation
- Conmed Corporation
- Richard Wolf GmbH
- Boston Scientific Inc.
- Integra LifeSciences Holdings Corporation
- Aesculap Division
- Smith & Nephew Plc
- Medtronic
- NICO Corp.
Recent Developments in the Minimally Invasive Neurosurgery Devices Market
In May 2023, the commercial introduction of NeuroOne Medical Technologies Corporation's Evo sEEG electrode lineup in the United States was revealed. NeuroOne offers a complete range of electrode technologies to serve a US$100 million United States market for patients seeking definitive neurological operations.
In March 2022, NICO Corporation produced an adaptor for electromagnetic navigation when doing minimally invasive parafascicular surgery, offering neurosurgeons the option of performing frameless brain surgery. This implies that suitable patients no longer need to be trapped in a hard headframe throughout the navigation procedure.
Key Segmentations:
By Device Type:
- Surgical Devices
- Monitoring & Visualization Devices
- Endoscopy Devices
By Surgery Type:
- Urological
- Vascular
- Cardiac
- Gynaecological
- Gastrointestinal
- Cosmetic
- Bariatric
- Thoracic
- Breast
- Orthopedic
Purchase Now to Access Segment-specific Information, Uncover Key Trends, Drivers, and Challenges: https://www.futuremarketinsights.com/checkout/956
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s related ongoing Coverage in the Healthcare Domain:
Portable Medical Devices Market Share: The global portable medical devices market is projected to expand at a CAGR of 10.7% during the forecast period. The market is estimated to generate market revenue of US$ 163.84 billion by 2033, increasing from US$ 59.28 billion in 2023.
Helicobacter Pylori Non-Invasive Testing Market Size: The global helicobacter pylori non-invasive testing market is projected to register at a moderate-paced CAGR of 4.4% over the forecast period. By 2033, demand for helicobacter pylori non-invasive testing is expected to reach a high of US$ 1000.57 Million.
Minimally Invasive Spine Technologies Market Demand: The global market for minimally invasive spine technologies market is expected to be driven by the fewer incisions on the body, increase in aging population and increase in back pain population.
Non-invasive Surgical Wound Closure Market Share: The global non-invasive surgical wound closure market is estimated to be valued at US$ 2,192.3 billion in 2022. This market is expected to grow at a CAGR of 4.1% over the forecast period (2022 to 2032) to reach a market size of US$ 3,404.6 billion by 2032.
Non-invasive Colon Cancer Screening Market Growth: The market for non-invasive colon cancer screening is growing in terms of adoption, the present use of non-invasive colon cancer screening is visible in healthcare settings like hospitals.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
